Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan
· Delayed Price · Currency is TWD 50.30
+0.20 (0.40%)
May 14, 2025, 2:32 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 16.54 billion as of May 14, 2025. Its market cap has decreased by -0.75% in one year.
Market Cap
16.54B
Enterprise Value
14.96B
Revenue
605.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.30
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 16.54B, an increase of 483.28%. That is a compound annual growth rate of 19.76%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 171.52B |
| Caliway Biopharmaceuticals | 110.55B |
| Bora Pharmaceuticals Co., LTD. | 74.21B |
| Lotus Pharmaceutical | 60.03B |
| Polaris Group | 33.16B |
| Oneness Biotech | 28.27B |
| Pegavision | 26.95B |
| Lumosa Therapeutics | 26.52B |